| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |